K. Tyler McCullough

K. Tyler McCullough is a Senior Scientist at Life Edit Therapeutics since November 2021, previously holding the position of Scientist II. McCullough contributed to advancements in gene therapy technologies for retinal conditions, with a doctoral dissertation focused on CRISPR/Cas9 and Adeno-Associated Viral gene therapy for treating autosomal dominant retinal disease. Prior experience includes serving as a Postdoctoral Researcher at Duke University, research roles at the FDA and Wilmer Eye Institute, and involvement in the Glycogen Storage Disease Program at the University of Florida. K. Tyler McCullough holds a PhD in Retinal Gene Therapy from the University of Florida, a Master's in Molecular Microbiology and Immunology from Johns Hopkins Bloomberg School of Public Health, and a Bachelor of Science in Microbiology and Cell Science from the University of Florida.